Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372